Literature DB >> 29443753

Intense 18F-FDG activity in aortoiliac bypass graft mimicking infection: A case report.

Minkyung Lee1, Jeong Seon Ryu, Chang Hae Suh, In Young Hyun.   

Abstract

RATIONALE: F-fluorodeoxyglucose (F-FDG) positron emission tomography/computed tomography (PET/CT) has the potential to become an important imaging tool for the diagnosis of suspected aortoiliac bypass graft infection (AGI). PATIENT CONCERNS: A 76-year-old man presented with incidental findings of intense F-FDG activity in previous operation site of aortobiiliac bypass graft in the initial staging of small cell lung cancer (SCLC). DIAGNOSES: Based on F-FDG PET/CT examination, preliminary differential diagnosis was AGI.
INTERVENTIONS: We performed laboratory tests and Galliun-citrate (Ga) single photon emission computed tomography/computed tomography (SPECT/CT). OUTCOMES: He had no constitutional symptoms and abnormal laboratory test results suggesting AGI. CT scan of the abdomen and pelvis showed no abnormal findings. Also, Ga planar scintigraphy and SPECT/CT imaging of the abdomen and pelvis failed to show abnormal Ga uptake in the same site of aortobiiliac bypass graft with F-FDG uptake. LESSONS: We present a case with postoperative inflammatory aortobiiliac bypass graft which was misdiagnosed as AGI based on intense F-FDG activity seen at PET/CT imaging.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29443753      PMCID: PMC5839814          DOI: 10.1097/MD.0000000000009876

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


Introduction

18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) scanning is a new tool for the diagnosis of aortic bypass graft infection (AGI).[ However, 18F-FDG PET/CT is based on the uptake of radioactive labeled FDG (a glucose analog) in metabolically active cells. Increased 18F-FDG uptake can be observed in infectious and inflammatory processes. Herein, we present a case of postoperative inflammatory aortobiiliac bypass graft which was misdiagnosed as AGI based on intense 18F-FDG uptake seen at PET/CT imaging.

Case report

A 76-year-old man admitted due to initial staging of small cell lung cancer (SCLC). He presented with cough and dyspnea for 1 month. Incidental finding of 18F-FDG uptake in the abdomen and pelvis (arrow) was observed in the initial staging with PET/CT (Fig. 1A). 18F-FDG uptake was seen in the SCLC of right lung and mediastinum. Metastatic lesions in the right lower neck and liver were also observed. Transverse fusion images revealed the site of 18F-FDG uptake in the abdomen and pelvis was previous operation site of aortobiiliac bypass graft (arrow) due to infrarenal abdominal aortic aneurysm 14 months ago (Fig. 1B). CT of the abdomen and pelvis failed no abnormal findings in the sites of aortobiiliac bypass graft (Fig. 2). Right hydroureteronephrosis was seen, it was due to urethral orifice obstruction by irregular enhancing nodule of prostate gland. Transrectal biopsy specimens were negative for malignancy. He had no constitutional symptoms and abnormal laboratory parameters suggesting AGI.
Figure 1

(A) Coronal fusion images of 18F-FDG PET/CT showed intense 18F-FDG uptake in the lesions (right lower neck, right lung, mediastinum, and liver) of small cell lung cancer. Also, there was incidental finding of 18F-FDG uptake in the abdomen and pelvis (arrow). (B) Transverse fusion images revealed the site of 18F-FDG uptake was previous aortobiiliac bypass site (arrow). 18F-FDG = 18F-fluorodeoxyglucose, PET/CT = positron emission tomography/computed tomography.

Figure 2

Computed tomography of the abdomen and pelvis failed no abnormal findings in the same sites of aortobiiliac bypass except right hydroureteronephrosis.

(A) Coronal fusion images of 18F-FDG PET/CT showed intense 18F-FDG uptake in the lesions (right lower neck, right lung, mediastinum, and liver) of small cell lung cancer. Also, there was incidental finding of 18F-FDG uptake in the abdomen and pelvis (arrow). (B) Transverse fusion images revealed the site of 18F-FDG uptake was previous aortobiiliac bypass site (arrow). 18F-FDG = 18F-fluorodeoxyglucose, PET/CT = positron emission tomography/computed tomography. Computed tomography of the abdomen and pelvis failed no abnormal findings in the same sites of aortobiiliac bypass except right hydroureteronephrosis. The patient was referred for 67Gallium–citrate (67Ga) imaging to rule out AGI. 67Ga planar scintigraphy and single photon emission computed tomography/computed tomography (SPECT/CT) of the abdomen and pelvis was performed 48 hours after the intravenous injection of 67Ga (148 MBq). 67Ga planar scintigraphy showed similar 67Ga uptake in mediastinum and right lower neck seen at 18F-FDG PET/CT. In the abdomen and pelvis, 67Ga uptake which was suspicious for a physiologic bowel uptake was seen (arrow) (Fig. 3A). Transverse and coronal fusion images of SPECT/CT revealed no definite abnormal 67Ga uptake in the sites of aortobiiliac bypass graft (Fig. 3B and C). At the last follow-up, there has been no evidence of AGI, and the patient remains asymptomatic for infection. The institutional review board of the Inha University Hospital did not require ethical approval for reporting individual cases. Informed consent was given by the patient.
Figure 3

(A) 67Ga planar scintigraphy showed similar 67Ga uptake in mediastinum and right lower neck seen at 18F-FDG PET/CT, and there was suspicious physiologic uptake in bowel. (B and C) Coronal and transverse fusion images of 67Ga SPECT/CT revealed no definite abnormal 67Ga uptake in the previous aortobiiliac bypass sites with intense 18F-FDG uptake seen at PET/CT imaging. 18F-FDG = 18F-fluorodeoxyglucose, 67Ga = 67Gallium–citrate, PET/CT = positron emission tomography/computed tomography, SPECT/CT = single photon emission computed tomography/computed tomography.

(A) 67Ga planar scintigraphy showed similar 67Ga uptake in mediastinum and right lower neck seen at 18F-FDG PET/CT, and there was suspicious physiologic uptake in bowel. (B and C) Coronal and transverse fusion images of 67Ga SPECT/CT revealed no definite abnormal 67Ga uptake in the previous aortobiiliac bypass sites with intense 18F-FDG uptake seen at PET/CT imaging. 18F-FDG = 18F-fluorodeoxyglucose, 67Ga = 67Gallium–citrate, PET/CT = positron emission tomography/computed tomography, SPECT/CT = single photon emission computed tomography/computed tomography.

Discussion

AGI is associated with high morbidity and mortality. Therefore, a diagnostic tool is needed with the ability to discriminate well between the presence and the absence of AGI. 18F-FDG PET/CT has been suggested as a means to detect AGI. However, patterns of 18F-FDG uptake in uninfected grafts largely overlap with those of infected vascular grafts.[ This limits the diagnostic value of 18F-FDG PET/CT in identifying or ruling out AGI.[ In the initial staging of our patients with SCLC, intense activity of 18F-FDG in aortobiiliac bypass graft was incidental finding. There were no constitutional symptoms, signs, and CT findings suggesting AGI. We needed other imaging modalities including assessment of the patient's general condition and microbiological work-up. In this case, we used 67Ga imaging for accurate diagnosis of AGI, because 67Ga imaging has been widely used for detecting infection focus.[ The negative uptake of 67Ga in this case supported 18F-FDG uptake mimicking AGI. The addition of SPECT/CT imaging provided addicted values in anatomic information for interpreting physiologic bowel activity of 67Ga.[ This case shows intense 18F-FDG activity in the sites of aortobiiliac bypass graft does not usually mean infected grafts. This false-positive 18F-FDG uptake may be due to postoperative changes or a chronic inflammatory reaction induced by the graft itself. Our case implies that an accurate diagnosis of AGI cannot be reached with positive 18F-FDG PET/CT imaging alone but requires clinical history, laboratory test results, and overlapping imaging findings.
  9 in total

1.  Gallium-67 SPECT/CT for abdominal abscess.

Authors:  Mei-Fang Cheng; Jei-Yie Huang; Deng-Yu Han; Pei-Ying Hsu; Ruoh-Fang Yen
Journal:  Clin Nucl Med       Date:  2011-03       Impact factor: 7.794

2.  Ga-67 and CT fusion imaging of an infected aortic graft.

Authors:  Kevin London; Robert Howman-Giles
Journal:  Clin Nucl Med       Date:  2008-01       Impact factor: 7.794

3.  67Ga SPECT/CT aids in the diagnosis of occult infected common iliac artery aneurysm.

Authors:  Mei-Fang Cheng; Kao-Lang Liu; Yu-Feng Lin; Kai-Yuan Tzen; Ruoh-Fang Yen
Journal:  Clin Nucl Med       Date:  2013-07       Impact factor: 7.794

4.  Differential FDG-PET Uptake Patterns in Uninfected and Infected Central Prosthetic Vascular Grafts.

Authors:  P Berger; I Vaartjes; A Scholtens; F L Moll; G J De Borst; B De Keizer; M L Bots; J D Blankensteijn
Journal:  Eur J Vasc Endovasc Surg       Date:  2015-07-09       Impact factor: 7.069

5.  Gallium SPECT/CT for permanent catheter infection.

Authors:  Tzyy-Ling Chuang; Yuh-Feng Wang
Journal:  Clin Nucl Med       Date:  2014-03       Impact factor: 7.794

6.  Detection of aortic graft infection by 18-fluorodeoxyglucose positron emission tomography combined with computed tomography.

Authors:  Gustaf Tegler; Jens Sörensen; Martin Björck; Irina Savitcheva; Anders Wanhainen
Journal:  J Vasc Surg       Date:  2007-04       Impact factor: 4.268

7.  18F-FDG uptake in noninfected prosthetic vascular grafts: incidence, patterns, and changes over time.

Authors:  Zohar Keidar; Natalia Pirmisashvili; Max Leiderman; Samy Nitecki; Ora Israel
Journal:  J Nucl Med       Date:  2014-02-10       Impact factor: 10.057

8.  SPECT/CT of axillofemoral graft infection.

Authors:  Allen Lee; Heather Biggs; Stephanie Chen; Nicolas Urriola; Smeer Aggarwal; Hashim Al-Gailani; Robert Mansberg
Journal:  Clin Nucl Med       Date:  2008-05       Impact factor: 7.794

9.  Diagnosis and follow-up of chronic bacterial prostatitis with recurrent urinary tract infection detected by 67Ga scintigraphy and SPECT/CT.

Authors:  Jun Ho Kim; Ji-Hyeon Baek; Jin Soo Lee; In Young Hyun
Journal:  Clin Nucl Med       Date:  2013-11       Impact factor: 7.794

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.